Package 67877-526-05

{"route": ["ORAL"], "spl_id": "05aa3d63-f0b2-4aff-8c82-847eec936579", "openfda": {"nui": ["N0000175427", "N0000190114", "N0000185503", "N0000182137", "N0000187061"], "unii": ["A6IEZ5M406"], "rxcui": ["616749", "728231"], "spl_set_id": ["5b254a8e-db88-49be-bb48-e6d2847f8ab3"], "pharm_class_epc": ["Anti-anginal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67877-526-05)", "package_ndc": "67877-526-05", "marketing_start_date": "20201202"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (67877-526-38)  / 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "67877-526-38", "marketing_start_date": "20201202"}, {"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67877-526-60)", "package_ndc": "67877-526-60", "marketing_start_date": "20201202"}], "brand_name": "Ranolazine", "product_id": "67877-526_05aa3d63-f0b2-4aff-8c82-847eec936579", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Anti-anginal [EPC]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "67877-526", "generic_name": "Ranolazine", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ranolazine", "active_ingredients": [{"name": "RANOLAZINE", "strength": "1000 mg/1"}], "application_number": "ANDA209953", "marketing_category": "ANDA", "marketing_start_date": "20201202", "listing_expiration_date": "20261231"}